Michael Berk
Affiliations: | University of Melbourne, Parkville, Victoria, Australia |
Area:
Bipolar Disorder, Psychoharmacology, Early Psychosis, Telemedicine,Google:
"Michael Berk"Mean distance: 15.95 (cluster 29)
Children
Sign in to add trainee| Francesco M. S. Giorlando | grad student | 2008- | University of Melbourne |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Barbosa IG, Miranda AS, Berk M, et al. (2024) The involvement of the microbiota-gut-brain axis in the pathophysiology of mood disorders and therapeutic implications. Expert Review of Neurotherapeutics. 1-15 |
| Herr K, Berk M, Huang WL, et al. (2024) Anhedonia in Major Depressive Disorder: Prevalence and Treatment Expectations and Satisfaction with Treatment Goals Among Patients and Physicians in Asia-Pacific. Neuropsychiatric Disease and Treatment. 20: 2177-2191 |
| Giménez-Palomo A, Chamdal AK, Gottlieb N, et al. (2024) Efficacy and tolerability of monoamine oxidase inhibitors for the treatment of depressive episodes in mood disorders: A systematic review and network meta-analysis. Acta Psychiatrica Scandinavica |
| Anmella G, Meehan A, Ashton M, et al. (2023) Exploring Clinical Subgroups of Participants with Major Depressive Disorder that may Benefit from Adjunctive Minocycline Treatment. Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology. 22: 33-44 |
| Sarmiento A, Dean OM, Kavanagh BE, et al. (2023) The Influence of Personality Disorder Symptoms on Treatment Outcomes in Bipolar Disorder: A Secondary Analysis of a Randomised Controlled Trial. Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. 7067437231213558 |
| Schwartz OS, Amminger P, Baune BT, et al. (2023) The Study of Ketamine for Youth Depression (SKY-D): study protocol for a randomised controlled trial of low-dose ketamine for young people with major depressive disorder. Trials. 24: 686 |
| McIntyre RS, Alsuwaidan M, Baune BT, et al. (2023) Treatment-resistant depression: definition, prevalence, detection, management, and investigational interventions. World Psychiatry : Official Journal of the World Psychiatric Association (Wpa). 22: 394-412 |
| Marx W, Penninx BWJH, Solmi M, et al. (2023) Major depressive disorder. Nature Reviews. Disease Primers. 9: 44 |
| Russell SE, Wrobel AL, Ashton MM, et al. (2023) Does Post-traumatic Stress Disorder Impact Treatment Outcomes within a Randomised Controlled Trial of Mitochondrial Agents for Bipolar Depression? Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology. 21: 457-465 |
| Khanra S, Reddy P, Giménez-Palomo A, et al. (2023) Metabolic regulation to treat bipolar depression: mechanisms and targeting by trimetazidine. Molecular Psychiatry |